Bingliang Chen
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 7
- Immunology top 10%
- Immunotherapy and Immune Responses 4
-
- RNA Research and Splicing 4
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Ferroptosis and cancer prognosis 8
- Prostate Cancer Treatment and Research 5
- Renal cell carcinoma treatment 4
- Co-authors
- Alan P. WolffeEdward J. RebarYuxin LiangCasey C. CaseS. Kaye SprattAndrew C. JamiesonZhihai WuWeiwei Wu
- Cited by
- OncologyImmunologyMolecular Biology
- Journals
- Journal of Biological Chemistry (2 papers)Nature Medicine (2 papers)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Bingliang Chen
43 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Oncology 385
- Immunology 281
- Molecular Biology 524
- Cancer Research 95
- Radiology, Nuclear Medicine and Imaging 103
Countries citing papers authored by Bingliang Chen
This map shows the geographic impact of Bingliang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingliang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingliang Chen more than expected).
Fields of papers citing papers by Bingliang Chen
This network shows the impact of papers produced by Bingliang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingliang Chen. The network helps show where Bingliang Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bingliang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 11 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 33 | |
| 9 | 2023 | 16 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 16 | |
| 16 | 2020 | 87 | |
| 17 | Efficacy of anti-CTLA-4 antibody in the SA1N tumor model when combined with dexamethasone | 2007 | 5 |
| 18 | 2002 | 30 | |
| 19 | 2001 | 191 | |
| 20 | 'Ch'u Tz'u and shamanism in ancient China / | 1972 | 1 |
About Bingliang Chen
Bingliang Chen is a scholar working on Immunology, Oncology and Cancer Research, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Ferroptosis and cancer prognosis (8 papers), CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Prostate Cancer Treatment and Research (5 papers), Renal cell carcinoma treatment (4 papers), Immunotherapy and Immune Responses (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Oncology (385 citations), Immunology (281 citations) and Molecular Biology (524 citations). Bingliang Chen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Alan P. Wolffe, Edward J. Rebar, Yuxin Liang, Casey C. Case, S. Kaye Spratt, Andrew C. Jamieson, Zhihai Wu, Weiwei Wu, Junjian Liu and Shuaixiang Zhou. Their work appears in journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.